STAT+: Pharmalittle: Foundation representing BioNTech undermines a WHO program; Lander promoted vaccines while holding BioNTech stock

Rise and shine, everyone, another busy day is on the way. This morning is getting off to a fabulous start, though, as a delightfully warm sun is enveloping the subdued Pharmalot campus, where the official mascot is anxiously awaiting a play date and the coffee kettle is whistling away. This, of course, means we are about to quaff another cup of stimulation — golden French toast is our choice du jour — for those tracking this sort of thing. Meanwhile, we have assembled some tidbits for your pleasure. So, time to get cracking. Hope you have a smashing day, and do stay in touch. We always enjoy your tips and insights. …
As head of the Office of Science and Technology Policy, Eric Lander publicly promoted Covid-19 vaccination efforts while having a significant financial investment in one of the vaccine makers , Politico reports. Under the White House’s ethics agreement Lander signed, he had 90 days to divest stocks after Senate confirmation on May 28. He sold most in June — including stock in BioNTech ( BNTX ) — but waited until Aug. 5 to sell the remaining $500,000 to $1 million worth of stock. When Lander ultimately sold the stock 69 days after his confirmation, it was the company’s second-highest stock price ever at $404.92 a share, having shot up more than $50 a share from two days prior. Continue to STAT+ to read the full story…